The spliceosome as target for anticancer treatment

Br J Cancer. 2009 Jan 27;100(2):228-32. doi: 10.1038/sj.bjc.6604801. Epub 2008 Nov 25.

Abstract

The spliceosome is a ribonucleoprotein complex involved in RNA splicing, that is, the removal of non-coding introns from precursor messenger RNA. (Alternative) Splicing events may play an essential role in tumourigenesis. The recent discovery that the spliceosome is a target for novel compounds with anticancer activity opens up new therapeutic avenues.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Drug Design
  • Humans
  • Introns / genetics
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Ribonucleoproteins / genetics
  • Ribonucleoproteins / metabolism
  • Spliceosomes / drug effects*
  • Spliceosomes / metabolism

Substances

  • Antineoplastic Agents
  • Ribonucleoproteins